HELSINN BUILDING QUALITY CANCER CARE TOGETHER
LIVE

Serial Number

79202865

Owner

Helsinn Healthcare SA

Attorney

Amanda Laura Nye

Filing Date

Oct 3, 2016

Add to watchlist:

No watchlists yet
View on USPTO

HELSINN BUILDING QUALITY CANCER CARE TOGETHER Trademark

Serial Number: 79202865 • Registration: 5372161

HELSINN BUILDING QUALITY CANCER CARE TOGETHER is a trademark filed by Helsinn Healthcare SA on October 3, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Helsinn Healthcare SA

Via Pian Scairolo 9
Lugano 6912 , CH

Entity Type: 99

Trademark Details

Filing Date

October 3, 2016

Registration Date

January 9, 2018

Published for Opposition

October 24, 2017

Cancellation Date

April 15, 2025

Goods & Services

[ The bringing together, for the benefit of others, of a variety of goods, namely, chemical substances, chemical materials and chemical products, pharmaceutical products, sanitary products for medical purposes, dietetic substances for medical use, excluding the transport thereof, enabling customers and wholesalers to conveniently view and purchase those goods ]

Pharmaceutical products, namely, anti-inflammatory drugs, antiemetic drugs, [ drugs for the treatment of cancer, carcinoma, leukemia, lymphoma, melanoma, anti-tumor drugs, ] anti-emetic, anti-tumor and anticancer pharmaceutical preparations for the treatment of oncological diseases and the side effects of treatment [ ; drugs for use in case of ulcerative and inflammatory conditions, anti-anxiety drugs, anti-migraine drugs, cognition enhancing drugs, drugs for the prevention and treatment of gastroenterological, hepatologic, nephrologic and cardiovascular disorders of any origin; drugs for internal cleansing purposes, bowel cleansers and evacuants for medical and pharmaceutical purposes, veterinary vaccines and sanitary preparations for medical purposes; dietetic foods adapted for medical use ]

Scientific research and development of pharmaceuticals; scientific and industrial research for the development of drugs and chemical components [ , as well as technical and scientific consultancy in the fields of scientific research of chemical, biochemical and pharmaceutical technologies; engineering services including engineering surveys in the fields of chemical, biochemical and pharmaceutical technologies; provision of technological professional knowledge, particularly in the field of planning and design of technological development in franchising chemical, biochemical and pharmaceutical products ]

[ Chemical substances, namely, chemical compounds for analyses in laboratories for scientific purposes, other than for medical or veterinary use ]

Licensing in the field of chemical, biochemical and pharmaceutical products [ ; legal representation and advice, particularly before and during national procedures for the regulation of chemical, biochemical and pharmaceutical products ]

Treatment in the nature of chemical processing of chemical, biochemical and pharmaceutical products for third parties [ ; consulting services relating to the treatment of chemical, biochemical and pharmaceutical products; information and advisory services in the field of chemical, biochemical and pharmaceutical products treatment and processing ]

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jul 5, 2026 INNA
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 15, 2025 INTR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2025 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Oct 24, 2025 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Sep 27, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 27, 2025 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 23, 2025 INPR
NOTICE OF CANCELLATION SEC. 71 E-MAILED
Apr 15, 2025 NC71
CANCELLED SECTION 71
Apr 15, 2025 C71T
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Sep 30, 2024 PR75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 16, 2024 APRE
NEW REPRESENTATIVE AT IB RECEIVED
Jul 19, 2024 NREP
TEAS SECTION 71 & 15 RECEIVED
Dec 21, 2023 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 9, 2023 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 22, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 22, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 22, 2021 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 6, 2018 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Apr 16, 2018 XXSS
GENERIC MADRID TRANSACTION CREATED
Apr 16, 2018 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 9, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 9, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2017 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Oct 21, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 4, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 4, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 18, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 18, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 18, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 18, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 9, 2017 ERFR
FINAL REFUSAL MAILED
Aug 16, 2017 CNFR
FINAL REFUSAL WRITTEN
Aug 15, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2017 CRFA
ASSIGNED TO LIE
Jul 20, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2017 TROA
REFUSAL PROCESSED BY IB
Apr 8, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 21, 2017 RFCS
REFUSAL PROCESSED BY MPU
Mar 21, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 21, 2017 RFCR
NON-FINAL ACTION WRITTEN
Mar 20, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 14, 2017 MAFR
ASSIGNED TO EXAMINER
Mar 11, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 9, 2017 REPR